Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)

v3.19.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
Convertible Series F Preferred Stock
Convertible Series D Preferred Stock
Redeemable Convertible Series B Preferred Stock
Common Stock
Additional Paid-In Capital
Warrant
Accumulated Deficit
Total
Balance at Dec. 31, 2017 $ 1,777,781 $ 169,447 $ 822,201 $ 33,623 $ 9,444,831 $ 982,911 $ (14,030,871) $ (3,569,506)
Balance (in shares) at Dec. 31, 2017 2,000 200 2,833.55 33,622,829        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock based compensation expense       $ 2,500 227,109     229,609
Stock based compensation expense (in shares)       2,500,000        
Issuance of common stock net of issuance costs of $16,900       $ 32,500 (32,500)      
Issuance of common stock net of issuance costs of $16,900 (in shares)       32,500,000        
Conversion of Series B Preferred Stock and conversion liability into common stock at $0.10 and $0.001 per share     $ (822,201) $ 28,385 800,530     828,915
Conversion of Series B Preferred Stock and conversion liability into common stock at $0.10 and $0.001 per share (in shares)     (2,833.55) 28,385,000        
Conversion of Series D Preferred Stock to common stock at $0.10 per share   $ (169,447)   $ 2,000 167,447     169,447
Conversion of Series D Preferred Stock to common stock at $0.10 per share (in shares)   (200)   2,000,000        
Conversion of Series F Preferred Stock to common stock at $0.10 per share $ (1,777,781)     $ 20,000 1,757,781     1,777,781
Conversion of Series F Preferred Stock to common stock at $0.10 per share (in shares) (2,000)     20,000,000        
Conversion of secured convertible promissory note - related party and accrued interest       $ 9,000 1,691,878     1,700,878
Conversion of secured convertible promissory note - related party and accrued interest (in shares)       9,000,000        
Series B warrant exercises       $ 4,406 1,318,284     1,322,690
Series B warrant exercises (in shares)       4,406,250        
Net loss for the year             (8,213,793) (8,213,793)
Balance at Mar. 31, 2018       $ 132,414 15,375,360 982,911 (22,244,664) (5,753,979)
Balance (in shares) at Mar. 31, 2018       132,414,079        
Balance at Dec. 31, 2018       $ 133,908 16,230,956 1,297,991 (33,225,107) (15,562,252)
Balance (in shares) at Dec. 31, 2018       133,907,747        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock based compensation expense         171,493     171,493
Warrants issued in connection with convertible multi-draw credit agreement, related party           716,110   716,110
Beneficial conversion feature in connection with convertible multi-draw credit agreement - related party         1,584,850     1,584,850
Net loss for the year             (14,774,392) (14,774,392)
Balance at Mar. 31, 2019       $ 133,908 $ 17,987,299 $ 2,014,101 $ (47,999,499) $ (27,864,191)
Balance (in shares) at Mar. 31, 2019       133,907,747